Bluebird Bio Beats Investor Suit Over FDA Cancer Warning
By Sydney Price · May 27, 2025, 10:47 PM EDT
Massachusetts-based biotechnology company Bluebird Bio Inc. has beaten a shareholder suit accusing it of misleading investors about the likelihood of the U.S. Food and Drug Administration's decision requiring a "black box...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login